Clinical Trial Update: Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial is evaluating whether Advair (fluticasone propionate/salmeterol) and Flovent (fluticasone propionate) can reduce systemic inflammatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Advair (fluticasone propionate/salmeterol)
• Flovent (fluticasone propionate)

Snippet

Sponsor: University of British Columbia | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: UNKNOWN